Clinical trialNCT06918431RecruitingPhase 2Interventional

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

SponsorCity of Hope Medical CenterEnrollment53B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeLymphoblastic Lymphoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Ibrahim Aldoss
City of Hope Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope at Phoenix
Phoenix, Arizona, United States
Recruiting
City of Hope Medical Center
Duarte, California, United States
Ibrahim Aldoss
Recruiting
City of Hope at Irvine Lennar
Irvine, California, United States
Ibrahim Aldoss
Not, yet, recruiting
Uc San Diego Moores Cancer Center
La Jolla, California, United States
James K. Mangan
Not, yet, recruiting
Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
Patricia A. Young
Not, yet, recruiting
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
Wendy Stock
Not, yet, recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Mark B. Geyer
Not, yet, recruiting
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Anjali S. Advani
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 10 Oct 2025
Primary completion: 30 Mar 2029
Completion: 30 Mar 2029
Last update posted: 17 Mar 2026
Registered enrollment: 53
Registry id: NCT06918431

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.